BG

Bellevue Group Portfolio holdings

AUM $4.54B
1-Year Return 22.5%
This Quarter Return
+16.96%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
AUM
$1.82B
AUM Growth
+$366M
Cap. Flow
+$143M
Cap. Flow %
7.84%
Top 10 Hldgs %
36.79%
Holding
154
New
14
Increased
81
Reduced
30
Closed
17

Sector Composition

1 Healthcare 91.36%
2 Industrials 1.12%
3 Technology 0.88%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MRTX
126
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.06M 0.06%
14,500
-9,500
-40% -$696K
LH icon
127
Labcorp
LH
$23.2B
$894K 0.05%
6,804
-762
-10% -$100K
ZLAB icon
128
Zai Lab
ZLAB
$3.42B
$885K 0.05%
+30,000
New +$885K
MDCO
129
DELISTED
Medicines Co
MDCO
$811K 0.04%
+29,000
New +$811K
MCK icon
130
McKesson
MCK
$85.5B
$724K 0.04%
6,186
-693
-10% -$81.1K
AFMD
131
DELISTED
Affimed
AFMD
$704K 0.04%
16,750
-250
-1% -$10.5K
PBYI icon
132
Puma Biotechnology
PBYI
$253M
$663K 0.04%
+17,100
New +$663K
KURA icon
133
Kura Oncology
KURA
$713M
$486K 0.03%
+29,300
New +$486K
VAR
134
DELISTED
Varian Medical Systems, Inc.
VAR
$398K 0.02%
2,807
-315
-10% -$44.7K
LOXO
135
DELISTED
Loxo Oncology, Inc
LOXO
-8,600
Closed -$1.21M
ABBV icon
136
AbbVie
ABBV
$375B
0
ADAP
137
Adaptimmune Therapeutics
ADAP
$10.9M
-131,135
Closed -$754K
BMRN icon
138
BioMarin Pharmaceuticals
BMRN
$11.1B
-45,969
Closed -$3.91M
CLLS
139
Cellectis
CLLS
$269M
-46,750
Closed -$778K
GLPG icon
140
Galapagos
GLPG
$2.2B
0
HCSG icon
141
Healthcare Services Group
HCSG
$1.15B
-15,000
Closed -$603K
IOVA icon
142
Iovance Biotherapeutics
IOVA
$901M
-16,000
Closed -$142K
IRWD icon
143
Ironwood Pharmaceuticals
IRWD
$188M
-91,341
Closed -$793K
LGND icon
144
Ligand Pharmaceuticals
LGND
$3.25B
-38,264
Closed -$3.24M
MYGN icon
145
Myriad Genetics
MYGN
$615M
-31,900
Closed -$927K
NTLA icon
146
Intellia Therapeutics
NTLA
$1.29B
-15,834
Closed -$216K
OEF icon
147
iShares S&P 100 ETF
OEF
$22.1B
0
TEVA icon
148
Teva Pharmaceuticals
TEVA
$21.7B
-60,000
Closed -$925K
VYGR icon
149
Voyager Therapeutics
VYGR
$235M
-27,900
Closed -$262K
ITCI
150
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-52,600
Closed -$599K